OptiBiotix Health – shares up despite another word soup RNS announcement, looks much further upside ahead

Microbiome-focused products company OptiBiotix Health (OPTI) has again issued an RNS version of ‘War and Peace’ in the form of a “Commercial Update”. However after, eventually, getting to the end of the announcement, though there are some minor disappointments, there are significant positives which suggest material upside potential from a currently up to 19p share price, £18.6 million market cap.

OptiBiotix Health (#OPTI) – 2024 orders delivered “£869,507 (35% increase)”, Q1 2025 “have already passed sales orders for H1 2024”

OptiBiotix Health – first USA partner launch, Morepen excitement to follow! Strong Buy

OptiBiotix Health (OPTI) has issued a “Launch of Daily Nouri FeelFull product in America”-titled announcement. What is the significance of this from an up to 16p share price, £15.7 million market capitalisation, in response?

Tom Winnifrith reported to the FCA over Optibiotix

A number of you have sent me postings on the LSE Asylum by a cretin, skid35. It seems I have been reported to the FCA regarding Optibiotix (OPTI). Suffice to say skid35 is an illiterate bum, confusing queue and cue and is also talking cock. He states:

OptiBiotix Health (#OPTI) – launch of FeelFull prebiotic lemonade drink containing SlimBiome in America

BREAKING: Amazing Morepen video, the truth about Skins share sales, FYB with Optibiotix

It is not the big story but Steve O’Hara has confirmed he has a sell order in on Skinbiotherapeutics (SBTX) shares. It’s been there for a while and shares are only sold inn small volumes on up days. Those who think that Optibiotix (OPTI) is either the only seller or a big seller are kidding themselves. On some days in recent weeks O’Hara has accounted for c6% of volumes on most days it has been nil

OptiBiotix Health – poorly-produced “Launch of Dr Morepen” announcement but the potential compelling, Strong Buy

OptiBiotix Health (OPTI) has issued a “Launch of Dr Morepen LightLife in India”-titled announcement which would likely have helped the shares up much more than just under 3% to 17.25p if the company, its nominated adviser Cairn Financial, broker Peterhouse and PR adviser Walbrook could together have produced a more financially-informative announcement. But Tom spoke to CEO Steve O'Hara at length and maybe we can illuminate a bit.

OptiBiotix Health (#OPTI) – upcoming launch of “multiple” products under Dr Morepen's newly-developed LightLife brand in India

Has Optibiotix sold Skinbiotherapeutics shares? Steve O’Hara declines to deny

I wonder why shares in SkinBiotherapeutics (SBTX) have not raced ahead more on the news from Croda. One possible explanation put to me by Lemming investor is that Optibiotix (OPTI) has been reducing its holding which was last stated at 10.92%.

Optibiotix: would you Adam & Eve it? How is Neil Davidson not a trougher who misleads?

Optibiotix (OPTI) CEO Steve O’Hara was admitted to hospital with pneumonia on or around 26 September. Pretty soon he was having heart surgery. I revealed all this and eventually Optibiotix, now being run by chairman Neil Davidson issued comment on 23 October. I cannot see how what it said was not a lie.

BREAKING: Optibiotix, O’Hara resurfaces!

Well this is good news. More in hope that expectation I texted him asking when the launch in India of the Dr Morepen jv was due. This is the deal that is planned to deliver GP of £5-6 million a year to Optibiotix (OPTI) within five years.

BREAKING: The whole Steve O Hara health story Optibiotix is still not telling you

The GM called by Seneca in cahoots with Optibiotix (OPTI) to sack Steen Anderson at Probiotix (PBX) is over and as we knew would happen, the motion was rejected. I gather that at least one PDMR at Probiotix has already bought shares in the company as a result and more insider buying, of a material nature, will follow next week. Things are all good at Probiotix and at 4p-6p folks should just hold their nose when it comes to the spread and buy. My two year target remains 24p. But I have shocking news about Optibiotix.

OptiBiotix Health (#OPTI) – Peterhouse Capital refuses request for consent from company to be able to vote its shares at requisitioned General Meeting of ProBiotix Heath (#PBX)

BREAKING: Optibiotix: another rule broken

Well run companies do not breach listing and disclosure rules however minor. Small caps whose CEO has been hospitalized for five weeks and whose chairman is an over-paid bellend do as we have seen too any times of late. A kind reader alerts me to another rule breach by Optibiotix (OPTI).

Optibiotix FD walks and disgraced Neil Davidson dissembles on O’Hara health

It seems that almost none of you wish Neil Davidson to remain as chairman on Optibiotix (OPTI) and today throws up another reason why.

OptiBiotix Health (#OPTI) – Finance Director Graham Myers to “step down”, David Blain to join as acting FD, only provides on CEO Stephen O’Hara “recovering after a short illness and expects to be back at work shortly”

Reader Poll: who should be chairman of Optibiotix?

Make your vote with a deadline of 7 AM Wednesday. Should it be: Neil Davidson on £70,000 a year, Tom Winnifrith on £17,500 a yea, or Stuart Ashman on whatever he wants.

Breaking: Has Neil Davidson at Optibiotix awarded himself a bumper pay rise while pretending it was still austerity all round

Approaches are now being made, as a result of today’s bombshell expose and the blundering mess over Probiotix (PBX) to larger shareholders in Optibiotix (OPTI) to gauge support for sacking Neil Davidson as chairman, via a GM if needed. If proof were not needed that the company needs a complete overhaul pf cost control and corporate governance I have been told about the covert pay hike Davidson has awarded himself.

BREAKING: Optibiotix and the share issue cover up

It gives me no pleasure at all to write about what is still my largest individual holding in this way. But it appears that Optibiotix (OPTI) has issued a stack of shares without telling anybody and that Nomad Cairn and the Oxymorons at AIM Regulation are covering this up rather than forcing it to come clean. At the very least there needs to be a ‘fess up RNS and with it the resignation of chairman Neil Davidson.

Letter to AIM Regulation regarding Optibiotix and Steve O'Hara

I have written to the Oxymorons at AIM regulation regarding Optibiotix (OPTI) as those companies where I have large investments should be held to the same standards as other companies where I am not invested.